Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
10 eventsAntev Ltd. — PHASE2
University of Chicago — NA
Gustave Roussy, Cancer Campus, Grand Paris — PHASE2
National Taiwan University Hospital — PHASE2
Debiopharm International SA — PHASE2
Xiaojun Chen — PHASE2, PHASE3
Xiaojun Chen — PHASE2, PHASE3
Fudan University — PHASE2
Aadi Bioscience, Inc. — PHASE2
Janssen Pharmaceutica N.V., Belgium — PHASE3
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for GRFoma.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersPCR Oncology
📍 Arroyo Grande, California
City of Hope
📍 Duarte, California
USC Norris Comprehensive Cancer Center
📍 Los Angeles, California
👤 Janssen Research & Development, LLC Clinical Trial
Stanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
Travel Grants
No travel grants are currently matched to GRFoma.
Community
No community posts yet. Be the first to share your experience with GRFoma.
Start the conversation →Latest news about GRFoma
Disease timeline:
New recruiting trial: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
A new clinical trial is recruiting patients for GRFoma
New recruiting trial: Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
A new clinical trial is recruiting patients for GRFoma
New recruiting trial: Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
A new clinical trial is recruiting patients for GRFoma
New recruiting trial: A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
A new clinical trial is recruiting patients for GRFoma
New recruiting trial: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
A new clinical trial is recruiting patients for GRFoma
New recruiting trial: AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
A new clinical trial is recruiting patients for GRFoma
New recruiting trial: Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
A new clinical trial is recruiting patients for GRFoma
New trial: Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Altera
Phase PHASE2 trial recruiting. nab-sirolimus
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about GRFoma
Are there clinical trials for GRFoma?
Yes — 1 recruiting clinical trial is currently listed for GRFoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat GRFoma?
2 specialists and care centers treating GRFoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.